Linkedin
Sign in
Join
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
FFE+CEO RT
BrandStorm
Solutions & Pricing
Partner
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Create an account
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Home
About
Editor’s Corner
Contribute
Contact Us
Thought Leadership
Healthcare C-Suite Movements
Digital in Pharma
Events
Solutions & Pricing
Partner
Instagram
Linkedin
X
Subscribe
Subscribe
Facebook
Linkedin
X
Youtube
Hot topics
Cipla’s Leadership Transition from Umang Vohra to Achin Gupta: Succession Planning in Action
0
By Anup Soans | MedicinMan Cipla Limited has announced a...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Coughing All the Way to the Bank: The High Cost of India’s Booming Cough Syrup Market
0
India’s cough syrup market, worth over ₹21,800 crore in...
Why Most AI Healthcare Tools Stall at the Pilot Stage
0
Artificial intelligence (AI) in healthcare consistently demonstrates remarkable technical...
Breaking Performance Barriers
0
Articles by K. Hariram, Pankaj Mehrotra, Rinkesh Shah, Gopal Kishore, Amaninder S. Dhillon, Ramandish Arora, Mohit Kumar Bhutani, Richa Goyal, and Mahendra Kumar Rai
Facebook
Linkedin
X
Youtube
Healthcare Trends
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Marketing
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Policies/Sales
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Strategy
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Subscribe
Hot topics
Time for Indian Pharma to Dive into Digital
0
When was the first time that we heard the...
India’s Booming OTC Pain Management Market: Trends, Growth & Consumer Behaviors
0
India’s Booming Pain Management Market: Trends, Growth & Consumer...
Alok Sonig Appointed CEO of Rosemont Pharmaceuticals
0
Effective January 1, 2026, Rosemont Pharmaceuticals has announced the...
Culture and Resistance to Change – A Pharma SFE Adoption Case Study
0
As an MNC Head, I was one among the...
Medical Rep to Doctorate in Human Resources and Board of Directors
0
MVS Murthy I began my career as a Medical Rep...
Facebook
Linkedin
X
Youtube
Healthcare Trends
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Marketing
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Policies/Sales
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Strategy
The Architects of Immunity: How a Handful of Nations Are Shaping the Future of Global Health
0
The Paradox of Protection In the time it takes to...
Levamisole Withdrawn in EU: Will India’s Regulator Follow?
0
On February 13, 2026, the Pharmacovigilance Risk Assessment Committee...
Uniform Code for Pharmaceutical Marketing Practices: 2011 and Now
0
In September 2011, MedicinMan published a UCPMP Special Issue...
Aflibercept: When Originators Stop Fighting and Start Licensing
0
When Regeneron Pharmaceuticals and Bayer AG signed a licensing...
India’s Pharma Renaissance: Private Equity at the Helm
0
Indian pharmaceuticals have long been known as the “pharmacy...
Subscribe
Home
DSC_6609
DSC_6609
DSC_6609
